| Name | Title | Contact Details |
|---|
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.
Heartland Health Region is a Rosetown, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Development Centers Inc is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
United Allergy Labs is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Nellix Endovascular is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.